KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 83 filers reported holding KEROS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,517,277 | -49.4% | 62,650 | -46.2% | 0.01% | -54.5% |
| Q1 2023 | $4,975,404 | +1518.9% | 116,520 | +1720.6% | 0.01% | +1000.0% |
| Q4 2022 | $307,328 | -79.0% | 6,400 | -87.9% | 0.00% | -66.7% |
| Q2 2022 | $1,464,000 | +260.6% | 52,934 | +608.8% | 0.00% | +200.0% |
| Q1 2022 | $406,000 | +21.2% | 7,468 | +30.4% | 0.00% | 0.0% |
| Q4 2021 | $335,000 | -82.9% | 5,727 | -88.5% | 0.00% | -87.5% |
| Q3 2021 | $1,964,000 | +283.6% | 49,636 | +311.7% | 0.01% | +300.0% |
| Q2 2021 | $512,000 | +41.4% | 12,055 | +105.1% | 0.00% | 0.0% |
| Q1 2021 | $362,000 | -70.7% | 5,877 | -66.4% | 0.00% | -71.4% |
| Q4 2020 | $1,234,000 | – | 17,492 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |